AIHA Laboratory Accreditation Program

Industrial Hygiene in the Pharmaceutical Industry

SafeBridge has developed a new course to provide health and safety professionals from a range of disciplines with the tools necessary to conduct, implement and manage an industrial hygiene program in the research, development and manufacture of active pharmaceutical ingredients (APIs) and drug products.

This 1.5 (one and one-half) day course will provide industrial hygiene practices for:

  • Drug Innovators (small to large pharmaceutical companies)
  • Contract Manufacturing and Development Organizations (CMOs and CDMOs)
  • Contract Research Organizations (CROs)
  • Vendors (equipment and containment manufacturers, safety suppliers, and other support services)

Who should attend:

  • Industrial Hygienists (especially those without prior Pharmaceutical Industry experience)
  • Safety Professionals
  • Environmental Engineers
  • EHS generalists
  • Staff responsible for health and safety at R&D, pharma or API plants or facilities
  • Other job functions, e.g., engineering staff, who support pharmaceutical operations and are required to act as industrial hygiene support for their company

(Additional courses recommended for EH&S, engineering, toxicology, and industrial hygiene and safety personnel include SafeBridge Potent Compound Safety Boot Camps I and II, which specifically focus on potent compound safety and include aspects of industrial hygiene, toxicology, environmental toxicology, and risk communication.)


Your instructors will be board-certified health professionals in industrial hygiene and toxicology with many years of experience in the pharmaceutical industry. The agenda will include the following:

  • Interpreting information received from toxicologists and clinicians and appropriately applying to recognition of hazards
    • Interpretation of Safety Data Sheets and Occupational Health Categorization , Occupational Exposure Limit, and Acceptable Surface Limit documentation
  • Evaluating exposure potential for pharmaceutical, biopharmaceutical and chemical operations
    • Qualitative
    • Quantitative
  • Industrial hygiene analytical chemistry for APIs (air and surface methods)
    • Applying method sensitivity to field data collection
  • Assessing engineering control equipment containment and control performance
    • Setting a Control (or Containment) Performance Target or CPT
    • The ISPE Guide – "ISPE Good Practice Guide: Assessing the Particulate Containment Performance of Pharmaceutical Equipment (Second Edition), May 2012" (formerly SMEPAC)
    • Cross-contamination including tracking of contamination though airflow and on people and equipment. Monitoring material "tracking" by occupational hygiene work
  • Personal exposure monitoring (versus an OEL)
  • Surface monitoring (including practical exercise)
  • Industrial hygiene monitoring (air and surface)
    • Industrial hygiene equipment
    • Sampling plans
    • Sample handling to prevent contamination
    • Full shift monitoring (versus OEL as an 8-hr TWA)
    • Task-oriented monitoring
    • Observing and recording tasks undertaken
    • Sample submission
  • Results
    • Recording operations and results
    • Data interpretation, statistics and uncertainty
    • Interpreting results, communicating results and risk communication
  • Industrial hygiene program development
    • Health risk ranking
    • Program accountabilities
  • Controls
    • Connecting hazard and risk to control
    • Engineering controls, administrative controls and the role of personal protective equipment (PPE) including respiratory protective equipment (RPE)
  • Practical exercises and case studies
  • Q&A Roundtable


Registration Fee:

$1850 for the first attendee from a company; $1725 for each additional attendee from the same company